MiR-19b-3p, miR-125b, miR-21, and miR-205 promote the radiotherapy resistance of nasopharyngeal carcinoma by regulating the Bcl-2 gene family protein 6. This evidence concerns the gene BCL2 and nasopharyngeal carcinoma.